EP Patent

EP3698778A1 — Stabilized topical formulations containing core-shell microcapsules

Assigned to Sol Gel Technologies Ltd · Expires 2020-08-26 · 6y expired

What this patent protects

A composition for topical application comprising a plurality of first core-shell microcapsules comprising a first core that comprises between about 3% to 6% w/w benzoyl peroxide and a first shell that comprises a first inorganic polymer, and a plurality of second core-shell micro…

USPTO Abstract

A composition for topical application comprising a plurality of first core-shell microcapsules comprising a first core that comprises between about 3% to 6% w/w benzoyl peroxide and a first shell that comprises a first inorganic polymer, and a plurality of second core-shell microcapsules comprising a second core that comprises between about 0.05-0.1% w/w retinoid and at least one phase changing material and a second shell that comprises a second inorganic polymer, wherein the composition is an oil in water emulsion comprising a polyoxylstearate and a glycerylstearate at a ratio of 0.1:10 to 10:0.1.

Drugs covered by this patent

Patent Metadata

Patent number
EP3698778A1
Jurisdiction
EP
Classification
—
Expires
2020-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Sol Gel Technologies Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.